DNA damage, discoordinated gene expression and cellular senescence in osteoarthritic chondrocytes  by Rose, J. et al.
Osteoarthritis and Cartilage 20 (2012) 1020e1028DNA damage, discoordinated gene expression and cellular senescence in
osteoarthritic chondrocytes
J. Rose ya, S. Söder za, C. Skhirtladze z, N. Schmitz x, P.M. Gebhard k, S. Sesselmann{, T. Aigner k*
yDepartment of Orthopaedic and Trauma Surgery, University of Cologne, Joseph-Stelzmann-Str. 9, 50924 Cologne, Germany
z Institute of Pathology, University of Erlangen-Nürnberg, Krankenhausstr. 8-10, 91054 Erlangen, Germany
x Institute of Pathology, University Hospital Leipzig, Liebigstr. 26, 04103 Leipzig, Germany
k Institute of Pathology, Medical Center Coburg, Ketschendorfer Str. 33, 96450 Coburg, Germany
{Division of Molecular Immunology, Department of Internal Medicine III, Nikolaus-Fiebiger Center, University of Erlangen-Nürnberg, Glückstr. 6, 91054 Erlangen, Germanya r t i c l e i n f o
Article history:
Received 27 October 2011
Accepted 23 May 2012
Keywords:
Cartilage
Osteoarthritis
Cell senescence
Degeneration
DNA damage
DNA repair* Address correspondence and reprint requests t
Coburg, Institute of Pathology, Ketschendorfer Str. 33
Tel: 49-9561-226213; Fax: 49-9561-227590.
E-mail addresses: thomas.aigner@klinikum-cob
(T. Aigner).
a Both authors contributed equally to the work.
1063-4584/$ e see front matter  2012 Osteoarthriti
http://dx.doi.org/10.1016/j.joca.2012.05.009s u m m a r y
Objective: The initiation/progression factors of osteoarthritic (OA) cartilage degeneration and the involved
biological mechanisms remain rather enigmatic. One core reason for this might be a cellular senescence-
like phenotype of OA chondrocytes, which might show a fundamentally different behavior pattern
unexpected from the biological mechanism established in young cells.
Design: This study was designed to investigate one core property of senescent cells, the heterogeneity of
gene expression, in OA chondrocytes by double-labeling immunolocalization using two genes (vimentin,
S-100 protein) as surrogates, which are constitutively expressed by (normal) chondrocytes. The level of
genomic DNA damage in OA chondrocytes was compared to normal chondrocytes and in vitro experi-
ments designed to demonstrate that stochastic genomic DNA damage is able to induce heterogeneity of
gene expression in chondrocytes.
Results: We show a signiﬁcantly increased heterogeneity of gene expression for vimentin and S-100
protein as well as a signiﬁcantly increased genomic DNA damage in the OA compared to normal chon-
drocytes, whereas no evidence of critical telomere shortening was found. In vitro experiments demon-
strated that stochastic genomic DNA damage induced by increased oxidative or genotoxic stress is able to
induce the heterogeneity in gene expression found in the OA cells in situ.
Conclusions: Our results suggest that OA chondrocytes show a special form of age-related cell degener-
ation, “progressive/stress-induced senescence”, progressing over time due to accumulated DNA damage
and subsequent chaotic gene activation pattern. This promotes increased malfunctioning of the cells and
ﬁnally the loss of their capacity to keep up cell and tissue homeostasis, i.e., prevent OA.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a very common severe disabling disease,
particularly in the aging Western societies. Doubtless, biomechanical
factors and perpetuated use of joints during life contribute to their
degeneration; however the homeostasis of anabolic and catabolic
events on the molecular level also plays a crucial role for maintaining
the tissue integrity of the articular cartilage. This delicate balance of
anabolic and catabolic gene regulationwithin articular chondrocytes,
which is needed formaintaining functional cartilagematrix, is mainlyo: T. Aigner, Medical Center
, D-96450 Coburg, Germany.
urg.de, th.aigner@yahoo.de
s Research Society International. Pregulated by a balanced interplay between anabolic growth factors
such as bonemorphogenetic proteins (BMPs) and insulin-like growth
factors (IGFs), and catabolic cytokines such as interleukin 1ß (IL-1ß)
(for review see Aigner et al.1). All of these complex interactions are
based on genetic predisposition (for review see Ikegawa2) and epige-
netic modulation of the genome (for review see Roach and Aigner3).
Many data regarding these factors have accumulated over the last
decades, but still the initiation and progression of the disease process
andthe involvedbiologicalmechanismsremain ratherenigmatic.One
core reason for thiswas recently suggested to be that very old cells are
presentwithin the(agedand)OAarticular tissue4e8; in fact, thesecells
seem to have largely survived since the end of adolescent growth, i.e.,
more than 30e40 years in most individuals suffering from OA. These
old chondrocytes appear to have a senescent-like phenotype and
might show a fundamentally different behavior pattern unexpected
from behavior known in young (non-senescent) cells.ublished by Elsevier Ltd. All rights reserved.
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represents amajor hindrance to these cells to react in a bio-“logical”
manner, is a rather stochastic derangement of gene expression, i.e.,
highly increased expression of a wide array of genes. This is
particularly true if the senescent phenotype is directly linked to
DNA damage, as in the case of progressive/stress-induced senes-
cence (in contrast to replicative senescence, which is mainly caused
by chromosomal instability due to telomere shortening) after
repetitive cell duplication9,10. A chaotic gene expression pattern on
the cellular level appears to be one potentially important facet of
chondrocyte behavior in OA cartilage7,8, though this has never been
investigated systematically in the tissue.
In the present study, we analyzed the heterogeneity of gene
expression within OA compared to normal cartilage using double-
immunoﬂuorescence as well as immuno double labeling ﬂuores-
cence activated cell sorting (FACS) analysis. We also investigated
the senescent phenotype of the OA chondrocytes in particular by
demonstrating the increased cellular DNA damage without any
evidence of critical telomere shortening. We show that stochastic
DNA damage in articular chondrocytes can induce the senescent
phenotype as well as the discoordinated gene expression pattern,
which is typical for OA chondrocytes.
Material and methods
Cartilage samples
For the study of mRNA expression levels, cartilage from human
femoral condyles was processed as described previously11. Normal
articular cartilage (numbers are given in the respective sections)
was obtained from autopsies, within 48 h of death. OA cartilagewas
obtained from total knee replacement (numbers are given in the
respective sections). Cartilage was considered to be normal if it
showed no signiﬁcant surface ﬁbrillation. Cases of rheumatoid
arthritis were excluded from the study. Only primary degenerated
and not regenerative cartilage (osteophytic tissue) was used.
The studywas approvedby the ethics committee of theuniversity.
Histology and immunohistochemistry (double-
immunoﬂuorescence)
Histologic studies and conventional immunohistochemical
studies were performed on paraformaldehyde ﬁxed and parafﬁn
embeddedspecimensofnormal [n¼17;meanage58yrs (41e83yrs)]
and OA [n ¼ 16; mean age 67 yrs (54e78 yrs)] articular cartilage. For
histologic evaluation, tissue sections were stained with Hematoxylin
and Eosin (HE) staining and toluidine blue for sulfated proteoglycans
(PGs). Immunohistochemical studies were done with antibodies for
vimentin [mouse monoclonal clone V9.1., Dako (Hamburg, FRG),
dilution 1:200 no pretreatment] and S-100 [rabbit polyclonal,
labeling mostly S-100B, Dako, dilution 1:1000; predigestion pronase
(2 mg/ml, phosphate buffered saline (PBS), pH 7.3, 60 min at 37C;
Boehringer Mannheim; FRG)]. Vimentin was detected using a tyr-
amide-ampliﬁcation protocol (PerkinElmer, Rodgau e Jügesheim,
FRG) and Cy3-labeled streptavidin complexes (dilution 1:1000; Bio-
Genex, San Ramon, USA). S-100 protein was detected using Cy5-
labeled secondary antibodies (anti-rabbit; 1:100; Jackson Inc., Balti-
more, USA). Nuclei were counterstained with 40,6-diamidino-2-
phenylindole (DAPI) (1:10,000). For control, primary or secondary
antibodies were replaced by PBS or non-immune serum (BioGenex)
and the samples processed as described above. None of the control
samples showed any signiﬁcant staining. Fluorescence micrographs
were taken with an AX70 Olympus microscope and a DT5 Olympus
digital camera (Olympus, Tokyo, Japan). Pictures were systematically
evaluated by double-immunoﬂuorescence microscopy for positivityof vimentin and S-100 protein of preserved cells within chondrocyte
lacunae (as proven by positivity of DAPI). For statistical comparison
the ManneWhitney test was used.
Flow cytometry for vimentin/S-100 double expression
Chondrocytes were freshly isolated enzymatically as described
previously12 and directly used for FACS analysis. For these studies,
cells obtained from normal [n ¼ 8, mean age 64 yrs (52e72 yrs)]
and OA donors [n ¼ 7, mean age 69 yrs (57e78 yrs)] were used.
For each experiment 4.5  105 cells were ﬁxed and per-
meabilized in 200 ml 1% paraformaldehyd (PFA) (in PBS pH 7.2;
Merck, Darmstadt, FRG) for 10 min at 4C. The cells were washed
three times in PBS and resuspended in the antibody solution. The
anti vimentin (1:200) and anti S-100 (1:10,000; both Dako) anti-
bodies were incubated in 0.1% saponin (in PBS pH 7.4;
SigmaeAldrich, Taufkirchen, FRG) for 30 min at 37C. After pellet-
ing the cells werewashed three times in PBS supplementedwith 3%
fetal bovine serum (FBS) (Biochrom, Berlin, FRG). Then the sample
was incubated with a mixture of ﬂuoresceinisothiocyanat (FITC)-
labeled anti-rabbit (1:100; Jackson Inc.) and Cy5-labeled anti
mouse antibodies (1:200; Jackson Inc.) in 0.1% saponin PBS for
30 min at 37C. The cells were washed twice, resuspended in PBS
pH 7.2 containing 1% PFA and immediately measured with a Bec-
toneDickinson FACSCalibur cytometer (San Jose, USA).
For each sample, gates were applied to the forward scatter/side
scatter (FSC/SSC) to exclude cell debris (particles size <<5 mm) and
cell clusters (particles size >>15 mm). In each group 104 cells were
measured. Cells were considered to be S-100/vimentin double
positive when they were located in the upper right quadrant of the
FL-1 (S-100)/FL-4 (vimentin) diagram. The borders of the quadrants
were calibrated using measurements of single stained cells. For
statistical comparison the ManneWhitney test was used.
mRNA expression analysis e RNA isolation and cDNA
synthesis e real-time polymerase chain reaction (PCR)
Normal [n ¼ 10; mean age 64 yrs (42e72 yrs)] and OA articular
cartilage [n ¼ 15; mean age 68 yrs (57e78 yrs)] was obtained as
described above. Cartilage was frozen in liquid nitrogen immedi-
ately after removal and stored at e80C until required for RNA
isolation. Total RNA from cartilage tissue was isolated as described
previously13. First strand cDNA was synthesized using the First
Strand Synthesis Kit from Boehringer (Boehringer Mannheim, FRG),
using 2 mg RNA. Real-time PCR (TAQMAN, Applied Biosystems,
Foster City, USA) was utilized to detect proliferation-associated
gene Ki67 (MKI67) as well as telomerase (TERT) (Table I). Primers
(MWG Biotech, FRG) and TAQMAN probes (Eurogentec, Seraing,
Belgium) were designed using PRIMER EXPRESS software
(Applied Biosystems) and used as described previously12. For all
genes speciﬁc standard curves were performed in parallel using
sequence speciﬁc control probes to obtain quantiﬁable results. All
experiments were performed in triplicates. For standardization of
the gene expression levels as determined by TAQMAN analysis
mRNA ratios relative to the housekeeping gene glyceraldehyde
3-phosphate dehydrogenase (GAPDH) were calculated by dividing
the mRNA copy number of the respective gene by the copy number
obtained for GAPDH. Statistical evaluation of signiﬁcant differences
in expression levels was done by ManneWhitney test.
COMET assay
In order to evaluate DNA damage within the cells, the so-called
COMET assay was performed.
Table I
Sequences of primers and probes used for quantitative real-time PCR experiments
Gene Acc.-No. Primer/Probe Sequence [nM]* MgCl2y
GAPDH NM_002046 Forward 50-GAAGGTGAAGGTCGGAGTC-30 50 5.5
Reverse 50-GAAGATGGTGATGGGATTTC-30 900
Probe 50-CAAGCTTCCCGTTCTCAGCC-30 100
MKI67 NM_002417 Forward 50-CAGTGATCAACGCCGTAGGTC-30 900 6
Reverse 50-TCGGCTGATAGACACTCTCTTTTG-30 900
Probe 50-CTTCCAGCAGCAAATCTCAGACAGAGGTTC-30 100
TERT NM_198253 Forward 50-TGCAGAGCGACTACTCCAGCTAT-30 300 5
Reverse 50-AAAGAGTTTGCGACGCATGTT-30 300
Probe 50-CTCACCTTCAACCGCGGCTTCAA-30 100
* Concentration of primer/probe in TAQMAN reaction in nM.
y MgCl2 concentration in TAQMAN reaction in mM.
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and OA [n¼ 8; mean age 68 yrs (57e78 yrs)] cartilagewere isolated
as described previously12. To recover metabolic homeostasis after
enzymatic digestion, cells were initially cultured for 2 days in
plastic ﬂasks.
The COMETassaywas performed using the COMETAssay Reagent
Kit from Trevigen (Trevigen Inc, Gaithersburg, USA) according to
manufacturer’s instructions. Brieﬂy, primary chondrocytes were
trypsinized, 2 104 cells were mixed with LowMelting Agarose and
applied to a COMET slide. After lysis a horizontal electrophoresis at
1 V/cm and 300 mAwas performed for 20 min at 4C under alkaline
conditions (pH > 13). Subsequently the samples were dried and
stained with ethidiumbromide (2 mg/ml, SigmaeAldrich) for 2 min.
On average, 80 randomly selected cells per sample were captured
under an IX70 Microscope (Olympus) and digital ﬂuorescent images
were obtained using the analysis software (SIS, Muenster, FRG).
Pictures were analyzed and the tail moment was calculated
employing the macro driven Scion Image Software (Frederick,
Maryland, USA).
Proliferation-assay
Proliferation rates for cells treated with hydrogen peroxide
(H2O2) or tert-butylhydroperoxide (TBHP) were measured with
a chemiluminescence assay based on the measurement of BrdU
incorporation during DNA synthesis [Cell Proliferation ELISA, BrdU
(chemiluminescent), Roche, Mannheim, FRG] according to manu-
facturer’s instructions. Chemiluminescence was detected with
a Multilabel Counter Victor2 (PerkinElmer) and related to the
amount of DNA measured in parallel using the Quant-iT
PicoGreen dsDNA Assay Kit (Invitrogen, Karlsruhe, FRG).
Telomere Southern blotting and FACS analysis
Telomere length was analyzed by the Southern blot based
TeloTAGGG Telomere length assay (Roche) following the protocol of
the manufacturer using 2 mg genomic DNA isolated directly from
articular cartilage sample [normal: n ¼ 5; mean age 63 yrs
(52e72 yrs) and OA: n ¼ 15; mean age 64 yrs (44e78 yrs)]. Addi-
tionally, telomere length was analyzed by the “telomere PNA kit/
FITC for ﬂow cytometry” (Dako) according to the protocol supplied
by the manufacturer and measured with a BectoneDickinson
FACSCalibur cytometer [cartilage samples: normal: n ¼ 7; mean
age 62 yrs (52e70 yrs) and OA: n¼ 7; mean age 67 yrs (57e78 yrs)].
Cell isolation, culture and challenge with DNA-damaging agent
Chondrocytes of normal knee joints [n ¼ 4; mean age 56 yrs
(40e70 yrs)] were freshly isolated enzymatically as described
previously12 and cultured in high density monolayer cultures(105 cells/cm2) for 48 h and then challenged with 0.025e0.5 mM
H2O2, 5e10 mM TBHP, 0.1 mg/ml actinomycin D or 0.2 U/ml bleo-
mycin for 16 h. The resulting DNA damage was evaluated by the
COMET assay (pH 13.1). The (dis-)coordinate expression of vimen-
tin and S-100 protein was evaluated by FACS analysis as described
above. For statistical analysis Wilcoxon signed rang test for paired
probes was used.
Statistical analysis
For statistical analysis the non-parametric ManneWhitney or
Wilcoxon signed rang tests were used (using the SPSS-software).
“n” indicates independent experiments form different donors
(and not technical replicates). P-values <0.05 were considered
signiﬁcant.
Results
OA chondrocytes show a discoordinated expression of S-100
protein and vimentin compared to normal articular chondrocytes
Heterogeneity in gene expression patterns between different
samples of OA cartilage has been shown by many studies
convincingly. Microheterogeneity within the same sample has been
reported anecdotally8,14, but was never investigated on a system-
atic level. Therefore, in this study, we selected two genes, vimentin
and S-100 protein, which are expressed by nearly all articular
chondrocytes15. We performed double-immunoﬂuorescence in
order to evaluate co-expression levels of both genes in normal and
OA articular cartilage sections [nnormal ¼ 17; nOA ¼ 16, Fig. 1(a),
Supplementary Figs. 1 and 2]. Co-expression of both genes was
conﬁrmed in the vast majority of normal articular chondrocytes
and a signiﬁcant increase in a dissociated expression of both genes
in OA cells [Fig. 1(a), lower two panels, Fig. 1(b): normal vs OA:
96.5% (2.1%) to 90.4% (3.6%), P < 0.001]. Importantly, the
distribution of cells with a discoordinated expression pattern was
random and not related to any zone or focal areas. The superﬁcial
layer in normal and OA cartilage could not be compared as it is
missing in OA cartilage.
In parallel, a similar analysis was performed on isolated chon-
drocytes from eight normal and seven OA cartilages [Fig. 1(c and
d)]: co-immunostaining and subsequent FACS analysis revealed
similar results (P < 0.02).
OA articular chondrocytes show a senescent phenotype
Previous reports have suggested that OA chondrocytes show
a senescent phenotype and thus express e.g. the senescence-
associated ß-galactosidase6,16. Also, large scale gene expression
analysis could identify numerous genes related to cellular
Fig. 1. Analysis of the co-expression of vimentin and S-100 protein by double-immunoﬂuorescence: a: representative samples of normal (n) and OA cartilage tissue (middle panel:
one cells show no staining for S-100 protein, lower panel: one cell shows no staining for vimentin); b(1,2): graphical representation of the in situ double-immmunoﬂuorescence
analysis [b2: representing a dotblot for the single results (S-100-vim-double-positive; the single values, the mean and the 95% conﬁdence-interval are given) represented in b1 as
a bar]. c: FACS analysis of the co-expression of vimentin (Y-axis) and S-100 protein (X-axis) in isolated chondrocytes immediately after isolation. d(1,2): graphical representation of
the in vitro FACS analysis [d2: representing a dotblot for the single results (S-100-vim-double-positive; the single values, the mean and the 95% conﬁdence-interval are given)
represented in d1 as a bar].
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we investigated key characteristics of the two modes of senescence
in primary OA versus normal articular human chondrocytes: telo-
mere shortening for replicative senescence and accumulating DNA
damage for progressive/stress-induced senescence (for review see
Shay and Wright17).
OA chondrocytes show no critical telomere shortening
First, we investigated the presence of a signiﬁcant shortening of
the telomere length in the OA chondrocytes by Southern analysis.
These experiments revealed only a minor shortening of telomere
length in OA chondrocytes compared to normal ones [nnormal ¼ 5;
nOA ¼ 5; Fig. 2(a and b)]. Of note, no critical telomere shortening
[lower than 6e7 kb (for review see Shay and Wright17)] wasdetectable. Telomere FACS analysis using the “telomere PNA kit/FITC
for ﬂow cytometry” (Dako) conﬁrmed that there is no signiﬁcant
decrease in OA chondrocytes in telomere length (data not shown).
Conventional and real-time PCR revealed no expression of telo-
merase in any normal and OA cartilage sample (all samples
<0.00001/GADPH, data not shown; nnormal ¼ 10; nOA ¼ 15). Also the
expression of the Ki67 antigen, which is closely correlated to cell
proliferation18, remained very low, though it was signiﬁcantly
increased compared to the normal [Fig. 2(c); nnormal ¼ 8; nOA ¼ 16;
P < 0.001].
The genomic integrity is impaired in OA chondrocytes
For determining genomic DNA damage (namely double- and
single strand breaks as well as apurinic and apyrimidinic sites)
Fig. 2. a, b: Analysis of telomere length by Southern blotting analysis showing no signiﬁcant loss of telomere length in four analyzed OA versus three analyzed normal cases
[HT1080: human ﬁbrosarcoma cell line (ATCC: CCL-121 with a known telomere length of 5e7 kb); HTL1301: human T-cell leukemia (HPACC: No 01051619) cell line with known
telomere length (>25 kb34; b: schematic representation of average telomere length of all experiments). c: Expression analysis of Ki67 mRNA expression by real-time PCR [n ¼ 10,
mean 64 yrs (45e88 yrs); OA: n ¼ 15, mean age 73 yrs (60e85yrs)]. d, e: COMET analysis of chondrocytes directly isolated from normal and OA cartilage (e: schematic repre-
sentation). b, c, e: the single values, the mean and the 95% conﬁdence-interval are given.
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normal (n ¼ 3) and OA (n ¼ 8) cartilage was performed
[Fig. 2(dee)]. This revealed a signiﬁcantly higher DNA damage in
the OA versus the normal articular chondrocytes (tail moment 2.5
fold higher; P< 0.001). No correlation to the age of the patients was
found, both for normal and OA samples.
Genotoxic stress and genomic DNA damage are able to induce
stochastic gene expression in chondrocytes as well as a senescent-
like chondrocyte phenotype in vitro
After administration of classical genotoxic agents such as the
reactive oxygen species (ROS)-inducer H2O2 (0.5 mM) or DNA-
damaging agents actinomycin D (0.1 mg/ml) and bleomycin
(0.2 U/ml) for 16 h, increased DNA damage in the COMET assay
[n ¼ 4; Fig. 3(aee)]. Additionally, treatment with genotoxic agents
produced a senescence-like phenotype, observed by the up-
regulation of the senescence-associated ß-galactosidase[Fig. 3(feh)] and the suppression of cell proliferation at higher dosis
[Fig. 3(i)], though partly cytotoxic or pro-apoptotic effects cannot
be excluded by the technology applied.
Next, we investigated whether random DNA damage is able
to induce the heterogeneity of gene expression found within
the primary articular chondrocytes. Thus, freshly isolated
chondrocytes were subjected to genotoxic (bleomycin, actino-
mycin D) or oxidative stress (H2O2) (n ¼ 4; Fig. 4). Both types of
stressors led to a strong increase in DNA damage within the
cells as conﬁrmed by the COMET assay (pH 13.1) [Fig. 4(b)].
Though we cannot fully exclude an early apoptotic phenotype
as reason for the increased DNA fragmentation, no cytomor-
phological evidence was visible to us in phase contrast
microscopy.
FACS analysis after co-immunostaining for vimentin and S-100
protein revealed similar results for all three agents: a signiﬁcantly
(n ¼ 4; P < 0.02) increased dissociation of gene expression
compared to the control (untreated) cells [Fig. 4(c and d)].
Fig. 3. aee: COMET assay of normal primary human chondrocytes: a þ c: images of control cells, b: image of cells treated with 0.1 mg/ml actinomycin D (act D), d: image of cells
treated with 0.2 U/ml bleomycin (bleo), e: evaluation of tail moments in one exemplary case; the single values, the mean and the 95% conﬁdence-interval are given; feg:
b-galactosidase (b-gal) assay of primary human chondrocytes, f: image of control cells, g: image of cells treated with 0.2 U/ml bleomycin, h, i: evaluation of % b-gal(þ) cells (h) and
proliferative activity (i) of chondrocytes treated with H2O2 or TBHP (CPS: counts per second) in one exemplary case.
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In our study, we present the ﬁrst systematic experimental
evidence using two selected genes that suggests that OA chon-
drocytes show a signiﬁcantly increased discoordinated gene expres-
sion compared tonormal cells. This followsupageneral impressionof
heterogeneous gene expression in OA chondrocytes from previous
studies, which however presented only anecdotal evidence involving
many genes such as Smad proteins, mediators of the mitogen-acti-
vated protein (MAP) kinases signaling cascade etc.7,8,19. Though
clearly, all these genes can be individually down-regulated by many
different mechanisms, the completely patchy distribution of these
abnormal cells in our study explicitly argues against any systematic
(zonal, focal, etc.) regulation. This is particularly true for molecules
such as vimentin and S-100 protein, which are as yet unknowntargets of regulators within the cells, but are thought to be consti-
tutively expressed in adult chondrocytes7. Obviously, our data ask for
extension addressing other genes as well in future studies. Also, the
analysis of gene expression in situ on themRNA level, another option
which might provide more direct evidence of chaotic gene expres-
sion, represents at ﬁrst sight an appealing technical alternative.
However, in situ hybridization analysis appears not to be technically
feasible, most of all because the sensitivity of the technology is not
high enough to pick up gene expression levels of most genes in
normal (and OA) articular chondrocytes.
OA chondrocytes display a degenerative or “senescent”
cellular phenotype6,20,21 and are more fragile both in terms of
vitality as demonstrated by high rates of cell death after cell
isolation in vitro22,23 and their phenotypic instability in vivo7.
They also show increased expression of markers of cellular
Fig. 4. a: Analysis of the co-expression of vimentin and S-100 protein using FACS analysis after oxidative (500 mMH2O2) and genotoxic stress [0.1 mg/ml actinomycin (act D) D, 0.2 U/
ml bleomycin (bleo)]: freshly isolated normal primary articular chondrocytes were cultured for 48 h in high density monolayer culture and subsequently exposed to the oxidative
and genotoxic stressors for 16 h. b: The resulting DNA damage was evaluated by the COMET assay (pH 13.1). c: The (dis-)coordinate expression of vimentin and S-100 protein was
evaluated by FACS analysis (vimentin: Y-axis; S-100 protein: X-axis). d: graphical evaluation of the FACS analysis [n ¼ 4; mean age 56 yrs (40e70 yrs)]; the single values, the mean
and the 95% conﬁdence-interval are given.
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OA chondrocytes show no evidence of classical replicative
senescence in general: no critical telomere shortening was
observed in our and other studies25e27. Despite the absence of
telomerase expression in adult articular chondrocytes25,26 this is
not surprising for a largely post-mitotic cell such as the adult
chondrocyte. Even in OA cartilage, very low proliferative activity
is found14. The expression of Ki67, a proliferation speciﬁc antigen,
is increased, but still very low in OA chondrocytes. This minor
increase in proliferative activity might be reﬂected in the slight
reduction in telomere length found in OA cells14,28, as adult
chondrocytes do not express telomerase. Alternatively, this slight
reduction might also be mainly related to stress-induced telo-
mere derangement. Obviously, the situation would be very
different in childhood and adolescence, during which chon-
drocytes proliferate and loose some telomere length24.
Our data suggest that there is a signiﬁcant increase in DNA
damage in OA chondrocytes. A similar observation was recently
reported for a pig model of cartilage degeneration29. Though the
observed DNA damage might not directly lead to mutational
protein alterations; it might modulate or even inhibit gene tran-
scription activity e.g., by changing the binding capacity of tran-
scription factors. In most cells, signiﬁcant DNA damage would
induce apoptotic cell death, which is, however, rather rarely
encountered in OA chondrocytes14: again this supports a senescent
phenotype of OA chondrocytes, as one characteristic of senescent
cells is their resistance to apoptotic cell death30.
In this study, we show that DNA damage induces a senescent-
like phenotype in chondrocytes in vitro with typical core features
such as expression of senescence-associated ß-galactosidase and
inhibition of proliferative activity. However, future studies have to
further characterize the type of senescence induced. Whereas this
awaits further studies, we show in this work that H2O2 is not onlyable to induce DNA damage, but also gene expression heterogeneity
at least in two model molecules similar to that observed in OA
chondrocytes. The basic ﬁnding suggested by our data, that
increased stochastic DNA damage leads to diversiﬁcation of gene
expression (i.e., a stochastic or chaotic gene expression) is not
speciﬁc for OA chondrocytes, but has also recently been shown to
occur in cardiac myocytes31. These results in two different cellular
systems, both largely post-mitotic in the adult, support the concept
that a gradual increase in stochastic DNA damage and consequently
in transcriptional noise introduces phenotypic variation and
instability among the aged myocardiocytes and chondrocytes. This
would explain many features, particularly the heterogeneity of
chondrocyte behavior32 leading to the progressive decline in joint
cartilage function. The study on cardiomyocytes aging and our data
stress the notion that the diversiﬁcation of gene expression due to
stochastic DNA damage e besides regular cell functioning e is
a core mechanism in cellular aging in general and in OA cartilage
degeneration in particular.
The observed rather limited dissociation of gene expression
after DNA damage in vitro (<10%) as well as in vivo (in OA articular
cartilage) is to be expected: a higher aberration rate in single genes
would not be compatible with the survival of cells in any condition
even if one assumes redundancy of cellular pathways vital for the
cells. This limited DNA damage might allow the chondrocytes to
survive largely in normal conditions in which the cells do not need
to fulﬁll complex activities (except maintaining minimal cellular
function to provide low-level matrix turnover). However, these
minor alterations might be disastrous in the case of complex
cellular activities of the cells such as cartilage restoration after
tissue destruction: minor malfunctioning accumulates to major
disregulation as soon as a large number of transcription factors,
matrix protein genes etc. are involved all being exposed to potential
genetic damage.
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phenotype of OA chondrocytes, induced by a random genomic DNA
damage accumulation over time, most likely due to continuous or
even accelerated oxidative stress (for review see Afonso et al.33 and
by Henrotin et al.34) caused by a decline in the oxidative defense of
OA chondrocytes6. We suggest that the senescent cell phenotype is
different from replicative senescence proposed in previous
studies28,35, which might still contribute in special circumstances
such as post-traumatic OA. Most likely, OA chondrocytes show
progressive/stress-induced senescence, progressing over time due
to accumulated DNA damage and subsequent chaotic gene activa-
tion pattern (and not telomere shortening). A discoordinated gene
expression on the single-cell level as shown for OA chondrocytes in
this study is exactly one core characteristic of progressively sen-
escent cells31.
Altogether, primary OA is certainly based on a genetic back-
ground/predisposition and the cells follow per se basic biological/
biochemical rules. In contrast to chondrodysplastic joint degener-
ation, which is mainly explained by this, primary non-inherited OA
is suggested to be additionally driven by the progressive aging of
the cells due to accumulating stochastic DNA damage leading to
genetic diversity, heterogeneous gene expression and ﬁnally failing
of cell and tissue homeostasis.
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